1. COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon. (August 2021) Authors: Hasselbalch, H.C.; Skov, V.; Kjær, L.; Ellervik, C.; Poulsen, A.; Poulsen, T.D.; Nielsen, C.H. Journal: Cytokine & growth factor reviews Issue: Volume 60(2021) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Whole blood gene expression profiling in patients undergoing colon cancer surgery identifies differential expression of genes involved in immune surveillance, inflammation and carcinogenesis. Issue 2 (February 2019) Authors: Watt, S.K.; Hasselbalch, H.C.; Skov, V.; Kjær, L.; Thomassen, M.; Kruse, T.; Burton, M.; Gögenur, I. Journal: European journal of surgical oncology Issue: Volume 45:Issue 2(2019) Page Start: e3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗